Integra Retained Earnings from 2010 to 2025

IART Stock

USD 21.85 0.33 1.49%

Integra LifeSciences Retained Earnings yearly trend continues to be comparatively stable with very little volatility. Retained Earnings are likely to outpace its year average in 2025. Retained Earnings is the cumulative amount of net income that Integra LifeSciences Holdings retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

1995-09-30

Previous Quarter

920.5 M

Current Value

939.9 M

Quarterly Volatility

293.5 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Integra LifeSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integra LifeSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 147.9 M, Interest Expense of 74.2 M or Total Revenue of 1.7 B, as well as many indicators such as Price To Sales Ratio of 1.03, Dividend Yield of 3.0E-4 or PTB Ratio of 1.07. Integra financial statements analysis is a perfect complement when working with Integra LifeSciences Valuation or Volatility modules.

Check out the analysis of Integra LifeSciences Correlation against competitors.

Latest Integra LifeSciences' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Integra LifeSciences Holdings over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Integra LifeSciences' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Integra LifeSciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 939.91 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Integra Retained Earnings Regression Statistics

	Arithmetic Mean	468,339,922
	Coefficient Of Variation	68.91
	Mean Deviation	271,699,527
	Median	348,373,000
	Standard Deviation	322,741,359
	Sample Variance	104162T
	Range	1B
	R-Value	0.91
	Mean Square Error	18694.5T
	R-Squared	0.83
	Slope	61,851,499
	Total Sum of Squares	1562429.8T

Integra Retained Earnings History

	2025	986.9 M
	2024	939.9 M
	2023	946.9 M
	2022	879.1 M
	2021	698.6 M
	2020	532.3 M
	2019	398.6 M

Other Fundumenentals of Integra LifeSciences

Retained Earnings Total Equity

Integra LifeSciences Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Investments	Short Term Debt	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.45	0.85	0.85	0.96	0.99	0.96	0.98	0.73	0.01	0.86	0.84	-0.1	0.95	0.62	0.99	-0.64	0.89	0.88	0.18	0.34	0.85	0.73	0.16	0.6
Total Stockholder Equity	0.97		0.45	0.86	0.82	0.93	0.92	0.96	0.92	0.71	0.04	0.87	0.78	-0.15	0.93	0.5	0.95	-0.51	0.8	0.91	0.16	0.28	0.88	0.72	0.28	0.55
Net Debt	0.45	0.45		0.1	0.54	0.51	0.43	0.43	0.5	0.0	0.03	0.65	0.8	0.19	0.37	0.35	0.48	-0.73	0.65	0.39	0.1	-0.44	0.43	-0.12	0.69	-0.29
Retained Earnings	0.85	0.86	0.1		0.69	0.77	0.82	0.87	0.75	0.89	-0.09	0.61	0.56	-0.42	0.81	0.53	0.81	-0.21	0.61	0.74	0.04	0.39	0.73	0.9	0.06	0.76
Accounts Payable	0.85	0.82	0.54	0.69		0.92	0.84	0.78	0.85	0.47	-0.15	0.76	0.79	-0.06	0.86	0.59	0.86	-0.64	0.79	0.71	0.04	0.11	0.73	0.44	0.1	0.43
Net Receivables	0.96	0.93	0.51	0.77	0.92		0.96	0.9	0.96	0.59	0.0	0.86	0.85	-0.07	0.96	0.62	0.97	-0.69	0.87	0.82	0.17	0.3	0.81	0.56	0.08	0.52
Total Liab	0.99	0.92	0.43	0.82	0.84	0.96		0.93	0.98	0.72	-0.01	0.83	0.85	-0.06	0.93	0.68	0.99	-0.7	0.91	0.83	0.18	0.37	0.8	0.7	0.07	0.61
Total Current Assets	0.96	0.96	0.43	0.87	0.78	0.9	0.93		0.9	0.73	0.0	0.82	0.81	-0.22	0.9	0.55	0.93	-0.5	0.83	0.85	0.04	0.27	0.83	0.76	0.29	0.56
Intangible Assets	0.98	0.92	0.5	0.75	0.85	0.96	0.98	0.9		0.65	0.03	0.87	0.87	0.03	0.92	0.64	0.99	-0.77	0.92	0.85	0.27	0.33	0.81	0.63	0.11	0.54
Short Term Investments	0.73	0.71	0.0	0.89	0.47	0.59	0.72	0.73	0.65		-0.1	0.49	0.44	-0.27	0.61	0.43	0.71	-0.15	0.52	0.69	0.05	0.4	0.66	0.89	0.05	0.76
Short Term Debt	0.01	0.04	0.03	-0.09	-0.15	0.0	-0.01	0.0	0.03	-0.1		0.29	0.02	0.33	0.06	0.18	0.02	-0.05	-0.01	-0.01	0.5	0.59	-0.1	-0.05	0.05	-0.08
Common Stock	0.86	0.87	0.65	0.61	0.76	0.86	0.83	0.82	0.87	0.49	0.29		0.89	0.14	0.82	0.62	0.87	-0.68	0.88	0.86	0.25	0.24	0.85	0.45	0.37	0.18
Long Term Debt	0.84	0.78	0.8	0.56	0.79	0.85	0.85	0.81	0.87	0.44	0.02	0.89		0.04	0.76	0.71	0.86	-0.84	0.97	0.74	0.16	0.01	0.73	0.38	0.4	0.14
Treasury Stock	-0.1	-0.15	0.19	-0.42	-0.06	-0.07	-0.06	-0.22	0.03	-0.27	0.33	0.14	0.04		-0.19	-0.21	-0.02	-0.37	0.12	-0.1	-0.05	0.07	0.05	-0.33	0.0	-0.23
Property Plant Equipment	0.95	0.93	0.37	0.81	0.86	0.96	0.93	0.9	0.92	0.61	0.06	0.82	0.76	-0.19		0.6	0.94	-0.56	0.78	0.83	0.26	0.4	0.76	0.62	0.02	0.58
Current Deferred Revenue	0.62	0.5	0.35	0.53	0.59	0.62	0.68	0.55	0.64	0.43	0.18	0.62	0.71	-0.21	0.6		0.62	-0.59	0.72	0.48	0.44	0.37	0.35	0.42	-0.08	0.22
Good Will	0.99	0.95	0.48	0.81	0.86	0.97	0.99	0.93	0.99	0.71	0.02	0.87	0.86	-0.02	0.94	0.62		-0.7	0.9	0.87	0.21	0.34	0.85	0.68	0.14	0.58
Net Tangible Assets	-0.64	-0.51	-0.73	-0.21	-0.64	-0.69	-0.7	-0.5	-0.77	-0.15	-0.05	-0.68	-0.84	-0.37	-0.56	-0.59	-0.7		-0.85	-0.47	-0.31	-0.04	-0.46	-0.1	-0.13	-0.08
Long Term Debt Total	0.89	0.8	0.65	0.61	0.79	0.87	0.91	0.83	0.92	0.52	-0.01	0.88	0.97	0.12	0.78	0.72	0.9	-0.85		0.77	0.14	0.15	0.78	0.5	0.25	0.27
Capital Surpluse	0.88	0.91	0.39	0.74	0.71	0.82	0.83	0.85	0.85	0.69	-0.01	0.86	0.74	-0.1	0.83	0.48	0.87	-0.47	0.77		0.23	0.22	0.93	0.65	0.27	0.37
Deferred Long Term Liab	0.18	0.16	0.1	0.04	0.04	0.17	0.18	0.04	0.27	0.05	0.5	0.25	0.16	-0.05	0.26	0.44	0.21	-0.31	0.14	0.23		0.4	-0.06	0.02	-0.13	0.03
Short Long Term Debt	0.34	0.28	-0.44	0.39	0.11	0.3	0.37	0.27	0.33	0.4	0.59	0.24	0.01	0.07	0.4	0.37	0.34	-0.04	0.15	0.22	0.4		0.12	0.48	-0.56	0.6
Long Term Investments	0.85	0.88	0.43	0.73	0.73	0.81	0.8	0.83	0.81	0.66	-0.1	0.85	0.73	0.05	0.76	0.35	0.85	-0.46	0.78	0.93	-0.06	0.12		0.61	0.32	0.34
Net Invested Capital	0.73	0.72	-0.12	0.9	0.44	0.56	0.7	0.76	0.63	0.89	-0.05	0.45	0.38	-0.33	0.62	0.42	0.68	-0.1	0.5	0.65	0.02	0.48	0.61		0.02	0.77
Net Working Capital	0.16	0.28	0.69	0.06	0.1	0.08	0.07	0.29	0.11	0.05	0.05	0.37	0.4	0.0	0.02	-0.08	0.14	-0.13	0.25	0.27	-0.13	-0.56	0.32	0.02		-0.35
Capital Stock	0.6	0.55	-0.29	0.76	0.43	0.52	0.61	0.56	0.54	0.76	-0.08	0.18	0.14	-0.23	0.58	0.22	0.58	-0.08	0.27	0.37	0.03	0.6	0.34	0.77	-0.35

Click cells to compare fundamentals

About Integra LifeSciences Financial Statements

Integra LifeSciences shareholders use historical fundamental indicators, such as Retained Earnings, to determine how well the company is positioned to perform in the future. Although Integra LifeSciences investors may analyze each financial statement separately, they are all interrelated. The changes in Integra LifeSciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Integra LifeSciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Retained Earnings	939.9 M	986.9 M
Retained Earnings Total Equity	1 B	1.1 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Integra Stock Analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC